APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacokinetic Testing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmacokinetic Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

12 August 2026188 pages

Choose your research edition.

Industry ResearchPharmacokinetic Testing Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacokinetic Testing Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Pharmacokinetic Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacokinetic Testing Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacokinetic Testing Market Analysis and Forecast 2026-2032170 pages · $4,950 USD

Market perspective

The global Pharmacokinetic Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmacokinetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacokinetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacokinetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmacokinetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmacokinetic Testing include Certara, L.P., Evotec AG, Pacific BioLabs, GVK Biosciences Private Limited, SGS SA, LGC Limited, Pharmaceutical Product Development, LLC, Charles River Laboratories International, Inc. and Creative Bioarray, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmacokinetic Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacokinetic Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacokinetic Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmacokinetic Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmacokinetic Testing Segment by Company

Certara, L.P.

Evotec AG

Pacific BioLabs

GVK Biosciences Private Limited

SGS SA

LGC Limited

Pharmaceutical Product Development, LLC

Charles River Laboratories International, Inc.

Creative Bioarray

Pharmacokinetic Testing Segment by Type

Oral Dissolution Testing (FDC)

Intravenous Titration Test (IVRT)

Cell Line In-house Testing (ICR)

Pharmacokinetic Testing Segment by Application

Hospital

Clinic

Research Institutions

Pharmacokinetic Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetic Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmacokinetic Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacokinetic Testing industry.

Chapter 3: Detailed analysis of Pharmacokinetic Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacokinetic Testingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacokinetic Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Oral Dissolution Testing (FDC) Table 3. Key Players of Intravenous Titration Test (IVRT) Table 4. Key Players of Cell Line In-house Testing (ICR) Table 4. Global Pharmacokinetic Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Research Institutions Table 8. Global Pharmacokinetic Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Pharmacokinetic Testing Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Pharmacokinetic Testing Market Share by Region (2021-2026) Table 11. Global Pharmacokinetic Testing Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Pharmacokinetic Testing Market Share by Region (2027-2032) Table 13. Pharmacokinetic Testing Industry Trends Table 14. Pharmacokinetic Testing Industry Drivers Table 15. Pharmacokinetic Testing Industry Opportunities and Challenges Table 16. Pharmacokinetic Testing Industry Restraints Table 17. Global Pharmacokinetic Testing Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Pharmacokinetic Testing Revenue Market Share by Company (2021-2026) Table 19. Global Pharmacokinetic Testing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharmacokinetic Testing Key Company Head Office and Area Served Table 21. Global Pharmacokinetic Testing Company, Product Type & Application Table 22. Global Pharmacokinetic Testing Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharmacokinetic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Pharmacokinetic Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmacokinetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Pharmacokinetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Pharmacokinetic Testing Revenue Market Share by Type (2021-2026) Table 29. Global Pharmacokinetic Testing Revenue Market Share by Type (2027-2032) Table 30. Global Pharmacokinetic Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmacokinetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Pharmacokinetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Pharmacokinetic Testing Revenue Market Share by Application (2021-2026) Table 34. Global Pharmacokinetic Testing Revenue Market Share by Application (2027-2032) Table 35. Certara, L.P. Company Information Table 36. Certara, L.P. Business Overview Table 37. Certara, L.P. Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Certara, L.P. Pharmacokinetic Testing Product Portfolio Table 39. Certara, L.P. Recent Development Table 40. Evotec AG Company Information Table 41. Evotec AG Business Overview Table 42. Evotec AG Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Evotec AG Pharmacokinetic Testing Product Portfolio Table 44. Evotec AG Recent Development Table 45. Pacific BioLabs Company Information Table 46. Pacific BioLabs Business Overview Table 47. Pacific BioLabs Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Pacific BioLabs Pharmacokinetic Testing Product Portfolio Table 49. Pacific BioLabs Recent Development Table 50. GVK Biosciences Private Limited Company Information Table 51. GVK Biosciences Private Limited Business Overview Table 52. GVK Biosciences Private Limited Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. GVK Biosciences Private Limited Pharmacokinetic Testing Product Portfolio Table 54. GVK Biosciences Private Limited Recent Development Table 55. SGS SA Company Information Table 56. SGS SA Business Overview Table 57. SGS SA Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. SGS SA Pharmacokinetic Testing Product Portfolio Table 59. SGS SA Recent Development Table 60. LGC Limited Company Information Table 61. LGC Limited Business Overview Table 62. LGC Limited Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. LGC Limited Pharmacokinetic Testing Product Portfolio Table 64. LGC Limited Recent Development Table 65. Pharmaceutical Product Development, LLC Company Information Table 66. Pharmaceutical Product Development, LLC Business Overview Table 67. Pharmaceutical Product Development, LLC Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pharmaceutical Product Development, LLC Pharmacokinetic Testing Product Portfolio Table 69. Pharmaceutical Product Development, LLC Recent Development Table 70. Charles River Laboratories International, Inc. Company Information Table 71. Charles River Laboratories International, Inc. Business Overview Table 72. Charles River Laboratories International, Inc. Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Charles River Laboratories International, Inc. Pharmacokinetic Testing Product Portfolio Table 74. Charles River Laboratories International, Inc. Recent Development Table 75. Creative Bioarray Company Information Table 76. Creative Bioarray Business Overview Table 77. Creative Bioarray Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Creative Bioarray Pharmacokinetic Testing Product Portfolio Table 79. Creative Bioarray Recent Development Table 80. North America Pharmacokinetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 81. North America Pharmacokinetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 82. North America Pharmacokinetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 83. North America Pharmacokinetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 84. North America Pharmacokinetic Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Pharmacokinetic Testing Market Size by Country (2021-2026) Table 86. North America Pharmacokinetic Testing Market Size by Country (2027-2032) Table 87. Europe Pharmacokinetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 88. Europe Pharmacokinetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 89. Europe Pharmacokinetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 90. Europe Pharmacokinetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 91. Europe Pharmacokinetic Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Pharmacokinetic Testing Market Size by Country (2021-2026) Table 93. Europe Pharmacokinetic Testing Market Size by Country (2027-2032) Table 94. China Pharmacokinetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 95. China Pharmacokinetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 96. China Pharmacokinetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 97. China Pharmacokinetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia Pharmacokinetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 99. Asia Pharmacokinetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 100. Asia Pharmacokinetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 101. Asia Pharmacokinetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Pharmacokinetic Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Pharmacokinetic Testing Market Size by Country (2021-2026) Table 104. Asia Pharmacokinetic Testing Market Size by Country (2027-2032) Table 105. South America, Middle East & Africa Pharmacokinetic Testing Market Size by Type (2021-2026) & (US$ Million) Table 106. South America, Middle East & Africa Pharmacokinetic Testing Market Size by Type (2027-2032) & (US$ Million) Table 107. South America, Middle East & Africa Pharmacokinetic Testing Market Size by Application (2021-2026) & (US$ Million) Table 108. South America, Middle East & Africa Pharmacokinetic Testing Market Size by Application (2027-2032) & (US$ Million) Table 109. South America, Middle East & Africa Pharmacokinetic Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. South America, Middle East & Africa Pharmacokinetic Testing Market Size by Country (2021-2026) Table 111. South America, Middle East & Africa Pharmacokinetic Testing Market Size by Country (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Pharmacokinetic Testing Product Image Figure 2. Global Pharmacokinetic Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmacokinetic Testing Market Share by Type: 2025 VS 2032 Figure 4. Oral Dissolution Testing (FDC) Image Figure 5. Intravenous Titration Test (IVRT) Image Figure 6. Cell Line In-house Testing (ICR) Image Figure 7. Global Pharmacokinetic Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Pharmacokinetic Testing Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Research Institutions Image Figure 12. Global Pharmacokinetic Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 14. Global Pharmacokinetic Testing Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Pharmacokinetic Testing Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Pharmacokinetic Testing Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Pharmacokinetic Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pharmacokinetic Testing Revenue Market Share by Type (2021-2032) Figure 21. Global Pharmacokinetic Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pharmacokinetic Testing Revenue Market Share by Application (2021-2032) Figure 23. North America Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 24. North America Pharmacokinetic Testing Market Share by Type (2021-2032) Figure 25. North America Pharmacokinetic Testing Market Share by Application (2021-2032) Figure 26. North America Pharmacokinetic Testing Market Share by Country (2021-2032) Figure 27. United States Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 28. Canada Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 30. Europe Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pharmacokinetic Testing Market Share by Type (2021-2032) Figure 32. Europe Pharmacokinetic Testing Market Share by Application (2021-2032) Figure 33. Europe Pharmacokinetic Testing Market Share by Country (2021-2032) Figure 34. Germany Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 35. France Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 37. Italy Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 38. Russia Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 40. China Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 41. China Pharmacokinetic Testing Market Share by Type (2021-2032) Figure 42. China Pharmacokinetic Testing Market Share by Application (2021-2032) Figure 43. Asia Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 44. Asia Pharmacokinetic Testing Market Share by Type (2021-2032) Figure 45. Asia Pharmacokinetic Testing Market Share by Application (2021-2032) Figure 46. Asia Pharmacokinetic Testing Market Share by Country (2021-2032) Figure 47. Japan Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 51. India Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 52. Australia Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pharmacokinetic Testing Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Pharmacokinetic Testing Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Pharmacokinetic Testing Market Share by Country (2021-2032) Figure 57. Brazil Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 62. UAE Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 64. Chile Pharmacokinetic Testing Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Dissolution Testing (FDC)
  • Intravenous Titration Test (IVRT)
  • Cell Line In-house Testing (ICR)
Applications
  • Hospital
  • Clinic
  • Research Institutions
Companies covered
  • Certara, L.P.
  • Evotec AG
  • Pacific BioLabs
  • GVK Biosciences Private Limited
  • SGS SA
  • LGC Limited
  • Pharmaceutical Product Development, LLC
  • Charles River Laboratories International, Inc.
  • Creative Bioarray

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmacokinetic Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Dissolution Testing (FDC)
  5. 1.2.3 Intravenous Titration Test (IVRT)
  6. 1.2.4 Cell Line In-house Testing (ICR)
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Pharmacokinetic Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Research Institutions
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Pharmacokinetic Testing Growth Trends by Region
  14. 1.5.1 Global Pharmacokinetic Testing Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Pharmacokinetic Testing Market Size by Region (2021-2026)
  16. 1.5.3 Pharmacokinetic Testing Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Pharmacokinetic Testing Market Dynamics
  1. 2.1 Pharmacokinetic Testing Industry Trends
  2. 2.2 Pharmacokinetic Testing Industry Drivers
  3. 2.3 Pharmacokinetic Testing Industry Opportunities and Challenges
  4. 2.4 Pharmacokinetic Testing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmacokinetic Testing Revenue by Company (2021-2026)
  2. 3.2 Global Pharmacokinetic Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmacokinetic Testing Key Company Head office and Area Served
  4. 3.4 Global Pharmacokinetic Testing Company, Product Type & Application
  5. 3.5 Global Pharmacokinetic Testing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmacokinetic Testing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmacokinetic Testing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmacokinetic Testing Tier 1, Tier 2, and Tier 3
4 Pharmacokinetic Testing Market by Type
  1. 4.1 Global Pharmacokinetic Testing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmacokinetic Testing Market Size by Type (2021-2032)
  3. 4.3 Global Pharmacokinetic Testing Market Size Share by Type (2021-2032)
5 Pharmacokinetic Testing Market by Application
  1. 5.1 Global Pharmacokinetic Testing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmacokinetic Testing Market Size by Application (2021-2032)
  3. 5.3 Global Pharmacokinetic Testing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Certara, L.P.
  2. 6.1.1 Certara, L.P. Company Information
  3. 6.1.2 Certara, L.P. Business Overview
  4. 6.1.3 Certara, L.P. Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Certara, L.P. Pharmacokinetic Testing Product Portfolio
  6. 6.1.5 Certara, L.P. Recent Developments
  7. 6.2 Evotec AG
  8. 6.2.1 Evotec AG Company Information
  9. 6.2.2 Evotec AG Business Overview
  10. 6.2.3 Evotec AG Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Evotec AG Pharmacokinetic Testing Product Portfolio
  12. 6.2.5 Evotec AG Recent Developments
  13. 6.3 Pacific BioLabs
  14. 6.3.1 Pacific BioLabs Company Information
  15. 6.3.2 Pacific BioLabs Business Overview
  16. 6.3.3 Pacific BioLabs Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pacific BioLabs Pharmacokinetic Testing Product Portfolio
  18. 6.3.5 Pacific BioLabs Recent Developments
  19. 6.4 GVK Biosciences Private Limited
  20. 6.4.1 GVK Biosciences Private Limited Company Information
  21. 6.4.2 GVK Biosciences Private Limited Business Overview
  22. 6.4.3 GVK Biosciences Private Limited Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GVK Biosciences Private Limited Pharmacokinetic Testing Product Portfolio
  24. 6.4.5 GVK Biosciences Private Limited Recent Developments
  25. 6.5 SGS SA
  26. 6.5.1 SGS SA Company Information
  27. 6.5.2 SGS SA Business Overview
  28. 6.5.3 SGS SA Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 SGS SA Pharmacokinetic Testing Product Portfolio
  30. 6.5.5 SGS SA Recent Developments
  31. 6.6 LGC Limited
  32. 6.6.1 LGC Limited Company Information
  33. 6.6.2 LGC Limited Business Overview
  34. 6.6.3 LGC Limited Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 LGC Limited Pharmacokinetic Testing Product Portfolio
  36. 6.6.5 LGC Limited Recent Developments
  37. 6.7 Pharmaceutical Product Development, LLC
  38. 6.7.1 Pharmaceutical Product Development, LLC Company Information
  39. 6.7.2 Pharmaceutical Product Development, LLC Business Overview
  40. 6.7.3 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Product Portfolio
  42. 6.7.5 Pharmaceutical Product Development, LLC Recent Developments
  43. 6.8 Charles River Laboratories International, Inc.
  44. 6.8.1 Charles River Laboratories International, Inc. Company Information
  45. 6.8.2 Charles River Laboratories International, Inc. Business Overview
  46. 6.8.3 Charles River Laboratories International, Inc. Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Charles River Laboratories International, Inc. Pharmacokinetic Testing Product Portfolio
  48. 6.8.5 Charles River Laboratories International, Inc. Recent Developments
  49. 6.9 Creative Bioarray
  50. 6.9.1 Creative Bioarray Company Information
  51. 6.9.2 Creative Bioarray Business Overview
  52. 6.9.3 Creative Bioarray Pharmacokinetic Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Creative Bioarray Pharmacokinetic Testing Product Portfolio
  54. 6.9.5 Creative Bioarray Recent Developments
7 North America
  1. 7.1 North America Pharmacokinetic Testing Market Size (2021-2032)
  2. 7.2 North America Pharmacokinetic Testing Market Size by Type
  3. 7.2.1 North America Pharmacokinetic Testing Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmacokinetic Testing Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmacokinetic Testing Market Share by Type (2021-2032)
  6. 7.3 North America Pharmacokinetic Testing Market Size by Application
  7. 7.3.1 North America Pharmacokinetic Testing Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmacokinetic Testing Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmacokinetic Testing Market Share by Application (2021-2032)
  10. 7.4 North America Pharmacokinetic Testing Market Size by Country
  11. 7.4.1 North America Pharmacokinetic Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmacokinetic Testing Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmacokinetic Testing Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmacokinetic Testing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmacokinetic Testing Market Size (2021-2032)
  2. 8.2 Europe Pharmacokinetic Testing Market Size by Type
  3. 8.2.1 Europe Pharmacokinetic Testing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmacokinetic Testing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmacokinetic Testing Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmacokinetic Testing Market Size by Application
  7. 8.3.1 Europe Pharmacokinetic Testing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmacokinetic Testing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmacokinetic Testing Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmacokinetic Testing Market Size by Country
  11. 8.4.1 Europe Pharmacokinetic Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmacokinetic Testing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmacokinetic Testing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmacokinetic Testing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmacokinetic Testing Market Size (2021-2032)
  2. 9.2 China Pharmacokinetic Testing Market Size by Type
  3. 9.2.1 China Pharmacokinetic Testing Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmacokinetic Testing Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmacokinetic Testing Market Share by Type (2021-2032)
  6. 9.3 China Pharmacokinetic Testing Market Size by Application
  7. 9.3.1 China Pharmacokinetic Testing Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmacokinetic Testing Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmacokinetic Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmacokinetic Testing Market Size (2021-2032)
  2. 10.2 Asia Pharmacokinetic Testing Market Size by Type
  3. 10.2.1 Asia Pharmacokinetic Testing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmacokinetic Testing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmacokinetic Testing Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmacokinetic Testing Market Size by Application
  7. 10.3.1 Asia Pharmacokinetic Testing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmacokinetic Testing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmacokinetic Testing Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmacokinetic Testing Market Size by Country
  11. 10.4.1 Asia Pharmacokinetic Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmacokinetic Testing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmacokinetic Testing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmacokinetic Testing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmacokinetic Testing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmacokinetic Testing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmacokinetic Testing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmacokinetic Testing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmacokinetic Testing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmacokinetic Testing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmacokinetic Testing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmacokinetic Testing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmacokinetic Testing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmacokinetic Testing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmacokinetic Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmacokinetic Testing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmacokinetic Testing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmacokinetic Testing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst